Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Laboratory Products and Biopharma Services5.76B54.62%
Life Sciences Solutions2.36B22.34%
Analytical Instruments1.78B16.90%
Specialty Diagnostics1.12B10.60%
Eliminations-470M-4.46%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States22.01B51.36%
Other20.84B48.64%
